Optiv, eye drops, 10 ml

It belongs to the group of ophthalmic agents in combinations, is an artificial analogue of tears.

Carmellose sodium and glycerol have properties of corneal epithelium protector, improve corneal moistening with decreased tear fluid secretion and increase the stability of the tear film.

Indications

Symptomatic treatment of dry eye syndrome.

Pharmacological effect

Belongs to the group of ophthalmic drugs in combinations; it is an artificial analogue of tears.

Carmellose sodium and glycerol have protective properties of the corneal epithelium, improve corneal hydration with reduced tear secretion and increase the stability of the tear film.

Special instructions

The drug is intended for topical use only.

Do not use if the integrity of the film covering the neck of the bottle is damaged, the solution becomes cloudy or its color changes.

Do not touch the tip of the pipette to any surface, including the conjunctiva, to avoid contamination of the contents of the bottle. It is necessary to close the bottle immediately after using the drug.

Consult your doctor if you experience pain in the eye area, blurred vision, prolonged hyperemia or irritation of the mucous membranes of the eyes.

Also seek advice if there is no improvement with drug 2 and/or if you experience other side effects that worsen or do not resolve within 72 hours.

Impact on driving vehicles and performing potentially hazardous activities

If blurred vision is observed after installation, it is necessary to refrain from driving vehicles and engaging in potentially hazardous activities that require increased concentration and speed of psychomotor reactions until it is restored.

Active ingredient

Carmellose sodium, Glycerol

Composition

Active ingredients:

carmellose sodium (type 7H3SXF 10-15) 1.75 mg,

carmellose sodium (type 7M8SFPH) 3.25 mg,

glycerol 9 mg.

Excipients:

Erythritol 2.50 mg,

levocarnitine 2.50 mg,

boric acid 7.00 mg,

sodium borate decahydrate 2.00 mg,

sodium citrate dihydrate 1.00 mg,

potassium chloride 1.40 mg,

calcium chloride dihydrate 0.06 mg,

magnesium chloride hexahydrate 0.06 mg,

oxy-chloro complex stabilized [sodium chlorite, sodium chlorate, chlorine dioxide] 0.10 mg,

purified water to 1.00 ml.

Pregnancy

The use of the drug during pregnancy and lactation is possible with caution. There have been no strictly controlled studies in pregnant women and nursing mothers.

In animal studies, no adverse effects of the active components of the drug were revealed. Optiv is not absorbed from the mucosal surface, so there are no objective prerequisites for the possible excretion of its components in breast milk.

Use in children

Contraindicated in children under 18 years of age.

Contraindications

Hypersensitivity to the components of the drug,
children under 18 years of age (no experience of use).

With caution: during pregnancy and lactation (due to limited data).

Side Effects

When using the drug, the following adverse reactions may develop:

Violations of the organ of vision: often – hyperemia of the conjunctiva, hyperemia of the eyelids, blurred vision, feeling of dryness of the eye, discomfort when instilling, itching and irritation of the eyes, formation of crusts on the edge of the eyelid.

In the post-marketing period, reports of the following adverse reactions of the drug Optiv were received (frequency unknown): pain in the eye area, the appearance of discharge from the eye, sensation of a foreign body in the eye, swelling of the eyelid, increased lacrimation, photophobia.

Interaction

There is no data on drug interactions with Optiv.

When prescribed with other local ophthalmic agents, the interval between instillation of the drug Optiv and other eye drops should be at least 5 minutes in order to exclude the possibility of “washing out” the drug.

Storage conditions

At a temperature not exceeding 25 °C

Shelf life

2 years

Manufacturer

USA